Latest Lead News

Pure Resources Limited has advanced its Reedy Creek Garnet Project through a strategic alliance with SSH Group Ltd, alongside board changes and promising metallurgical results that underpin commercial potential.

Alchemy Resources has made significant strides in its June quarter exploration, identifying major lithium targets at Karonie and acquiring full iron ore rights at Bryah, while advancing base metals exploration in NSW.

European Lithium Limited reported strong Q2 2025 progress with significant share sales in Critical Metals Corp raising over A$12.8 million, alongside promising exploration and development updates across Greenland, Austria, Ireland, and Australia.

Renegade Exploration has acquired four promising projects in Nevada's Walker Lane trend, revealing impressive high-grade gold and silver samples, while advancing its Yukon and Australian assets amid a recent $1.8 million capital raise.

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Citigold Corporation Limited reports steady progress in exploration and mine design at its Charters Towers Gold Project, while actively pursuing funding partnerships to restart operations.

Lode Resources reports strong assay results from its Montezuma Antimony & Silver Project and announces a maiden resource estimate at Webbs Consol, while advancing drilling at its Magwood Antimony Project.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

Uscom Limited reported a significant revenue decline in Q4 2025 amid global market instability but is focusing on cost management and strategic partnerships to position for recovery.